95 related articles for article (PubMed ID: 18687938)
1. The potential of genotyping.
de Leon J
Science; 2008 Aug; 321(5890):769. PubMed ID: 18687938
[No Abstract] [Full Text] [Related]
2. [CYP genotyping in psychopharmacological treatment].
Bramness JG
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):480; author reply 480. PubMed ID: 16477294
[No Abstract] [Full Text] [Related]
3. [CYP genotyping in psychopharmacological treatment].
Rudberg I; Solberg DK; Refsum H
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2953-5. PubMed ID: 16276380
[No Abstract] [Full Text] [Related]
4. [Comments to the brochure "Genetic tests and drug monitoring" distributed by the Laboratoriet, Epilepsihospitalet in Dianalund].
Línnet K
Ugeskr Laeger; 2004 Jan; 166(1-2):70-1; author reply 71. PubMed ID: 14752999
[No Abstract] [Full Text] [Related]
5. Personalized drug therapy with pharmacogenetics. Part 1: Pharmacokinetics.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2006 Jan; 44(1):13-6. PubMed ID: 16475439
[No Abstract] [Full Text] [Related]
6. [Culture and biology in psychopharmacological treatment of ethnic minorities].
Nørregaard C
Ugeskr Laeger; 2012 Feb; 174(6):337-40. PubMed ID: 22310004
[TBL] [Abstract][Full Text] [Related]
7. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
[No Abstract] [Full Text] [Related]
8. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
9. Principles of pharmacogenetics--implications for the anaesthetist.
Iohom G; Fitzgerald D; Cunningham AJ
Br J Anaesth; 2004 Sep; 93(3):440-50. PubMed ID: 15220176
[No Abstract] [Full Text] [Related]
10. Cytochrome P450 enzymes and psychiatric drugs. How a patient's genetic profile and other medications can alter drug response.
Harv Ment Health Lett; 2009 Feb; 25(8):4-5. PubMed ID: 19241615
[No Abstract] [Full Text] [Related]
11. How to dose a psychotropic drug: beyond therapeutic drug monitoring to genotyping the patient.
Stahl SM
Acta Psychiatr Scand; 2010 Dec; 122(6):440-1. PubMed ID: 20880158
[No Abstract] [Full Text] [Related]
12. Is genetic testing for cytochrome P450 polymorphisms ready for implementation?
Matchar DB; Thakur M
Am Fam Physician; 2007 Aug; 76(3):348, 351. PubMed ID: 17708133
[No Abstract] [Full Text] [Related]
13. [Cardiovascular pharmacogenomics].
Ahlehoff O; Hansen PR
Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
[TBL] [Abstract][Full Text] [Related]
14. [Genetic tests give the finishing touch to individual drug dosage].
Sjöqvist F
Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
[No Abstract] [Full Text] [Related]
15. [Pharmacogenetics: where are we and where are we going to?].
Ferriols Lisart F; Ferriols Lisart R
Farm Hosp; 2003; 27(2):109-20. PubMed ID: 12717566
[No Abstract] [Full Text] [Related]
16. Cytochrome P450 3A pharmacogenetics: the road that needs traveled.
Flockhart DA; Rae JM
Pharmacogenomics J; 2003; 3(1):3-5. PubMed ID: 12629575
[No Abstract] [Full Text] [Related]
17. Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.
Ramey-Hartung B; El-Mallakh RS; Reynolds KK
Clin Lab Med; 2008 Dec; 28(4):627-43. PubMed ID: 19059067
[TBL] [Abstract][Full Text] [Related]
18. CNVs of human genes and their implication in pharmacogenetics.
Johansson I; Ingelman-Sundberg M
Cytogenet Genome Res; 2008; 123(1-4):195-204. PubMed ID: 19287156
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. [In case of risks and side effects: ask your genes, too].
Möritz A
Med Monatsschr Pharm; 2007 May; 30(5):179-83. PubMed ID: 17526394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
